SCHEMBL4958829

SCHEMBL4958829

CC(=O)Nc1cc(C)c(C)cc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 5/20 0.57
NPC1 O15118 4/20 0.57
RAB9A P51151 3/20 0.57
MAPT P10636 3/20 0.57
SMN1; SMN2 Q16637 5/20 0.51
GAA P10253 4/20 0.51
HPGD P15428 2/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 4/20 0.49
KDM4E B2RXH2 1/20 0.49
APOBEC3A P31941 1/20 0.49
GFER P55789 1/20 0.49
HDAC1 Q13547 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
PHPT1 Q9NRX4 1/20 0.49
KMT2A Q03164 5/20 0.47
MEN1 O00255 3/20 0.47
ESR1 P03372 1/20 0.44
PTPRB P23467 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5179041 0.86 POLB (0.65) POLBNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL5888424 0.85 POLB (0.56) POLBNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL774588 0.85 POLB (0.56) POLBNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL1647181 0.84 GAA (0.53) POLBNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL16841342 0.84 POLB (0.50) POLBNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL9313018 0.84 POLB (0.50) POLBNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL13947181 0.84 POLB (0.63) POLBNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL14354630 0.83 ESR1 (0.49) POLBNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL10306224 0.82 ALDH1A1 (0.54) POLBNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL29819513 0.81 ALDH1A1 (0.58) POLBNPC1RAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293782-A1 1,1,3-Trioxo-1,2,5-Thiadiazolidines and Their Use as Ptp-Ases Inhibitors NOVARTIS AG (CH) 2008-11-27 US disclosed
US-20070298348-A1 Silver Halide Color Photographic Light-Sensitive Material and Image Forming Method FUJIFILM CORPORATION (JP) 2007-12-27 US disclosed
US-7189501-B2 Silver halide color photographic photosensitive material FUJI PHOTO FILM CO., LTD. (JP) 2007-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293782-A1 1,1,3-Trioxo-1,2,5-Thiadiazolidines and Their Use as Ptp-Ases Inhibitors PTPRS, IRS1, PTPMT1 POLB 3613/4885NPC1 3787/4885RAB9A 2959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.